Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Covid-19 and Anosmia in Tehran, Iran Publisher Pubmed



Gilani S1 ; Roditi R2 ; Naraghi M3
Authors

Source: Medical Hypotheses Published:2020


Abstract

Patients with acute olfactory disorders typically present to the otolaryngologist with both acute hyposmia and less often with anosmia. With the onset of COVID-19 we have noticed an increase in the number of patients who have presented with new onset of complete smell loss to the senior author's practice in Tehran, Iran. This anosmia and the frequency with which patients present is highly unusual. Coronaviruses have been known to cause common cold symptoms. COVID-19 infections have been described as causing more severe respiratory infections and the symptoms reported by authors from Wuhan, China have not specifically included anosmia. We describe patients who have presented during a two-week period of the COVID-19 pandemic with complete loss of sense of smell. Most had either no symptoms or mild respiratory symptoms. Many had a normal otolaryngologic exam. A relationship between COVID-19 and anosmia should be considered during the pandemic. We hypothesize that the mechanism of injury is similar to that of other coronavirus infections that cause central and peripheral neurologic deficits. © 2020
Other Related Docs
8. Treatments for Olfactory Dysfunction in Covid-19: A Systematic Review, International Archives of Otorhinolaryngology (2024)
9. A Case of Multiple Sclerosis With Protracted Course of Covid-19, Infectious Disorders - Drug Targets (2022)
13. Renal Involvement in a Child With Covid-19 Infection and Its Management With Crrt, International Journal of Preventive Medicine (2022)
15. Coronavirus, Its Neurologic Manifestations, and Complications, Iranian Journal of Pediatrics (2020)
19. Cranial Nerve Involvement Among Covid-19 Survivors, Frontiers in Neurology (2023)
20. Neurologic Presentations of Covid-19: A Case Series, Archives of Clinical Infectious Diseases (2022)